Evidence map›Paper›PMID 42011218›Full record

ArticleEClinicalMedicine2026

Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.

Tomasz Wróbel, Elżbieta Kalicińska, Jan Maciej Zaucha, Marta Morawska, Krzysztof Giannopoulos, Krzysztof Jamroziak, Ewa Lech-Marańda, Michał Taszner, Agnieszka Szeremet, Bartosz Małecki and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Tomasz WróbelWrocław Medical University, Wrocław, Poland.
Elżbieta KalicińskaWrocław Medical University, Wrocław, Poland.
Jan Maciej ZauchaMedical University of Gdańsk, Gdańsk, Poland.
Marta MorawskaMedical University of Lublin, Lublin, Poland.
Krzysztof GiannopoulosMedical University of Lublin, Lublin, Poland.
Krzysztof JamroziakMedical University of Warsaw, Warsaw, Poland.
Ewa Lech-MarańdaInstitute of Hematology and Blood Transfusion, Warsaw, Poland.
Michał TasznerMedical University of Gdańsk, Gdańsk, Poland.
Agnieszka SzeremetWrocław Medical University, Wrocław, Poland.
Bartosz MałeckiPoznań University of Medical Sciences, Poznań, Poland.
Agnieszka Druzd-SitekMaria Sklodowska-Curie National Research Institute of Oncology, Poland.
Anna Łojko-DankowskaPoznań University of Medical Sciences, Poznań, Poland.
Dominik DytfeldPoznań University of Medical Sciences, Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2025.103383.].

Identifiers

PMID42011218
PMCPMC13091732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.